Carlos Bueso-Ramos
Overview
Explore the profile of Carlos Bueso-Ramos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
5783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urrutia S, Kantarjian H, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, et al.
J Hematol Oncol
. 2024 Nov;
17(1):112.
PMID: 39548557
The outcomes of patients with acute myeloid leukemia (AML) and bone marrow fibrosis (MF) are not well defined. The study objectives were to evaluate the degrees of MF in AML,...
2.
Kontoyiannis P, Peddireddy A, Sasaki K, Chien K, Senapati J, Montalban-Bravo G, et al.
Leuk Res
. 2024 Nov;
147:107612.
PMID: 39536685
No abstract available.
3.
Kim D, Jia F, Patel K, Bose P, Wang S, Bueso-Ramos C, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Aug;
24(11):e878-e882.
PMID: 39107203
Background: KIT p.D816 mutation is strongly associated with systemic mastocytosis (SM). Next-generation sequencing (NGS) is now routinely performed in almost all bone marrow sample and KIT mutations are detected from...
4.
Montalban-Bravo G, Rodriguez-Sevilla J, Swanson D, Kanagal-Shamanna R, Hammond D, Chien K, et al.
Leukemia
. 2024 Feb;
38(5):1178-1181.
PMID: 38418609
No abstract available.
5.
Thongon N, Ma F, Baran N, Lockyer P, Liu J, Jackson C, et al.
Nat Commun
. 2024 Feb;
15(1):1203.
PMID: 38331987
DNA damage resistance is a major barrier to effective DNA-damaging therapy in multiple myeloma (MM). To discover mechanisms through which MM cells overcome DNA damage, we investigate how MM cells...
6.
Hu S, Jabbour E, Hu C, Tang G, Wang W, Medeiros L, et al.
Am J Hematol
. 2024 Jan;
99(4):721-726.
PMID: 38240333
No abstract available.
7.
Montalban-Bravo G, Kanagal-Shamanna R, Li Z, Hammond D, Chien K, Rodriguez-Sevilla J, et al.
Br J Haematol
. 2023 Aug;
203(4):581-592.
PMID: 37608562
Chronic myelomonocytic leukaemia (CMML) is a haematological disorder with high risk of transformation to acute myeloid leukaemia (AML). To characterize the phenotypic and genomic patterns of CMML progression, we evaluated...
8.
Urrutia S, Chien K, Li Z, Bataller A, Almanza E, Sasaki K, et al.
Am J Hematol
. 2023 Jul;
98(10):E281-E284.
PMID: 37515433
Evaluation of IPSS-M and exploratory prognostic model for MDS at the time of HMA failure.
9.
Fang H, Beird H, Wang S, Ibrahim A, Tang Z, Tang G, et al.
Leukemia
. 2023 Jul;
37(9):1919-1921.
PMID: 37443196
No abstract available.
10.
Urrutia S, Li Z, Almanza E, Bataller A, Kanagal-Shamanna R, Senapati J, et al.
Leukemia
. 2023 May;
37(6):1397-1400.
PMID: 37185307
No abstract available.